Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice.

Mandava P, Dalmeida W, Anderson JA, Thiagarajan P, Fabian RH, Weir RU, Kent TA.

Transl Stroke Res. 2010 Sep;1(3):170-7. doi: 10.1007/s12975-010-0026-4.

PMID:
24323522
2.

Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke.

Barreto AD, Albright KC, Hallevi H, Grotta JC, Noser EA, Khaja AM, Shaltoni HM, Gonzales NR, Illoh K, Martin-Schild S, Campbell MS 3rd, Weir RU, Savitz SI.

Stroke. 2008 Dec;39(12):3231-5. doi: 10.1161/STROKEAHA.108.521054. Epub 2008 Sep 4.

3.

Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS 3rd, Cacayorin ED, Grotta JC, Noser EA.

Stroke. 2007 Jan;38(1):80-4. Epub 2006 Nov 22.

PMID:
17122433
4.

Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system.

Weir RU, Marcellus ML, Do HM, Steinberg GK, Marks MP.

AJNR Am J Neuroradiol. 2003 Apr;24(4):585-90.

Supplemental Content

Support Center